RXRX250103C6500
- 1.20
- +0.45+60.00%
Recursion Pharmaceuticals Newsroom
Cathie Wood's Ark Invest Books Profits On Hot AI Stock Palantir, Sells Bitcoin ETF Shares As BTC Starts 2025 On A Positive Note
Trending Industry Today: Serve Robotics Leads Gains In NVIDIA Portfolio Stocks
Nio, Unity Software And Other Big Stocks Moving Higher On Thursday
Trending Industry Today: Nano X Imaging Leads Gains In NVIDIA Portfolio Stocks
Recursion Pharmaceuticals, Inc.'s (NASDAQ:RXRX) 30% Share Price Surge Not Quite Adding Up
Oncology in Focus: How Emerging Therapies Are Reshaping Cancer Treatment
Trending Industry Today: Arm Holdings Leads Losses In NVIDIA Portfolio Stocks
Is Recursion Pharmaceuticals Stock a Millionaire Maker?
Express News | Recursion Pharmaceuticals Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
Trending Industry Today: Applied Digital Leads Gains Pre-Market In NVIDIA Portfolio Stocks
Trending Industry Today: Serve Robotics Leads Losses In NVIDIA Portfolio Stocks
Express News | Recursion Pharmaceuticals Inc - Registering for Resale 3.5 Mln Shares of Class a Common Stock
Express News | Recursion Pharmaceuticals Inc - Files Prospectus Supplement
Trending Industry Today: SoundHound AI Leads Losses In NVIDIA Portfolio Stocks
Jim Cramer Says He Was Wrong on NVIDIA Holding Recursion Pharmaceuticals (RXRX)
Trending Industry Today: SoundHound AI Leads Gains In NVIDIA Portfolio Stocks
Trending Industry Today: Applied Digital Leads Gains In NVIDIA Portfolio Stocks
Recursion Pharmaceuticals' (RXRX) AI-Driven Cancer Treatment Shows Promise in Early Trials
Hold Rating for Recursion Pharmaceuticals Amid Early Efficacy Signals and Financial Concerns
10 Health Care Stocks Whale Activity In Today's Session